Zimmer Biomet Holdings (NYSE:ZBH) has had a rough month with its share price down 5.4%. However, stock prices are usually driven by a company’s financials over the long term, which in this case look ...

Principal Financial Group Inc. lowered its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 4.0% ...

Principal Securities Inc. boosted its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 23.7% in ...

Zimmer Biomet ZBH has been facing a difficult macroeconomic situation, which has raised expenses. Its leveraged capital ...

Zimmer Biomet Holdings, Inc. ZBH posted fourth-quarter 2024 adjusted earnings per share (EPS) of $2.31, beating the Zacks Consensus Estimate by a penny. The adjusted figure increased 5% year over year ...

Zimmer Biomet Holdings Inc is a global leader in medical technology, specializing in designing and manufacturing orthopedic reconstructive products, including knee and hip replacements. Beyond ...

Investors in Zimmer Biomet Holdings Inc (Symbol: ZBH) saw new options begin trading today, for the March 2026 expiration. One of the key data points that goes into the price an option buyer is ...

The upcoming report from Zimmer Biomet (ZBH) is expected to reveal quarterly earnings of $2.30 per share, indicating an increase of 4.6% compared to the year-ago period. Analysts forecast revenues ...

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products ...

1 Day ZBH 1.14% DJIA 0.16% S&P 500 0.24% Health Care/Life Sciences -0.46% ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...